비교리스트

 카트 문의
시장보고서
상품코드
1552519

3D 미세유체 세포배양 시장 규모, 점유율, 동향, 산업 분석 보고서 : 구성요소별, 용도별, 최종사용자별, 지역별 - 시장 예측(2024-2032년)

3D Microfluidic Cell Culture Market Size, Share, Trends, Industry Analysis Report: By Component, By Application, By End-User, and By Region - Market Forecast, 2024 - 2032
발행일: | 리서치사: Polaris Market Research | 페이지 정보: 영문 117 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

Polaris Market Research의 최신 조사에 따르면, 세계 3D 미세유체 세포배양 시장 규모는 2032년까지 3억 9,395만 달러에 달할 것으로 예상됩니다. 이 조사 보고서는 현재 시장 역학에 대한 자세한 인사이트와 향후 시장 성장에 대한 분석을 제공합니다.

3D 미세유체 세포배양 시장은 세포생물학의 발전, 고충실도 체외모델에 대한 수요 증가, 연구개발 투자 증가로 인해 크게 성장하고 있습니다. 주요 촉진요인으로는 기존 2D 배양으로는 인간 조직의 복잡성을 모방할 수 없는 경우가 많기 때문에 보다 정확한 약물 검사 및 질병 모델링에 대한 요구가 있습니다. 미세유체 시스템의 기능성과 확장성을 향상시키는 통합 센서 및 첨단 소재와 같은 기술 혁신으로 비즈니스 기회가 확대되고 있습니다. 데이터 분석을 위한 인공지능의 통합과 개인 맞춤형 의료의 발전은 시장의 잠재력을 더욱 높여줄 것입니다. 전반적으로 기존 세포배양법의 한계를 극복하고 생명공학 및 의약품의 발전을 지원하면서 시장은 꾸준히 성장할 것으로 예상됩니다.

미세유체공학의 기술 발전은 세포 환경의 정확성과 제어를 향상시켜 보다 정확한 생리적 조건의 시뮬레이션을 가능하게함으로써 시장 수익을 견인하고 있습니다. 신약 개발 및 맞춤 의료 분야에서 첨단 체외 모델에 대한 수요가 증가함에 따라 이러한 시스템이 인간 반응 및 질병 모델링 예측을 개선함에 따라 수요를 더욱 촉진하고 있습니다. 또한, 생물 의학 연구에 대한 투자 증가와 고처리량 스크리닝 방법으로의 전환이 시장 성장에 기여하고 있습니다.

3D 미세유체 세포배양 시장 보고서 하이라이트

3D 미세유체 디바이스 분야는 첨단 세포배양 시스템의 채택이 증가하고 실험 정확도 향상에 대한 관심이 높아지면서 압도적인 강세를 보이고 있습니다. 이 분야는 지속적인 기술 혁신으로 디바이스 성능이 향상되고 있어 가장 높은 성장이 예상됩니다.

제약 개발 및 신약 개발 분야는 제약 개발 프로세스를 간소화하기 위한 고처리량 예측 모델에 대한 수요가 증가하면서 시장을 주도하고 있습니다. 이 분야는 제약 연구 가속화에 중요한 역할을 하기 때문에 견고한 성장세를 유지할 것으로 예상됩니다.

3D 미세유체 세포배양 시장의 주요 기업으로는 Emulate Inc., TissUse GmbH, MIMETAS BV, InSphero AG, CN Bio Innovations Ltd., Kirkstall Ltd., Hurel Corporation, AIM Biotech, Elveflow, Blacktrace Holdings Ltd., Tara Biosystems Inc., Ascendance Biotechnology Inc., Synthecon Incorporated, Fluidigm Corporation, Organovo Holdings Inc. 등이 있습니다.

북미는 주요 생명공학 기업의 강력한 존재감과 풍부한 연구 자금의 혜택을 누리고 있는 지배적인 지역입니다. 아시아태평양은 연구 인프라의 급속한 발전과 의료 기술 혁신에 대한 투자 증가로 인해 가장 높은 성장률을 보이고 있습니다.

목차

제1장 소개

제2장 주요 요약

제3장 조사 방법

제4장 세계의 3D 미세유체 세포배양 시장 인사이트

  • 시장 현황
  • 3D 미세유체 세포배양 시장 역학
    • 성장 촉진요인과 기회
      • AI와 머신러닝의 통합이 시장 성장을 견인
      • HTS(High Throughput Screening) 플랫폼 개발이 시장을 견인
    • 성장 억제요인과 과제
      • 3D 미세유체 세포배양 기술에 대한 초기 투자가 시장 성장을 방해하고 있다
  • PESTEL 분석
  • 3D 미세유체 세포배양 시장 용도 동향
  • 밸류체인 분석
  • COVID-19의 영향 분석

제5장 세계의 3D 미세유체 세포배양 시장 : 구성요소별

  • 주요 조사 결과
  • 소개
  • 3D 미세유체 디바이스
  • 미디어
  • 시약
  • 소모품

제6장 세계의 3D 미세유체 세포배양 시장 : 용도별

  • 주요 조사 결과
  • 소개
  • 의약품 발견과 개발
  • 조직공학
  • 재생의료
  • 암 조사
  • 줄기세포 조사
  • 장기 칩
  • 독성 시험
  • 질환 모델
  • 기타

제7장 세계의 3D 미세유체 세포배양 시장 : 최종사용자별

  • 주요 조사 결과
  • 소개
  • 제약·바이오테크놀러지 기업
  • 학술조사기관
  • 병원과 진단 센터
  • 임상시험수탁기관(CRO)
  • 기타

제8장 세계의 3D 미세유체 세포배양 시장 : 지역별

  • 주요 조사 결과
  • 소개
    • 3D 미세유체 세포배양 시장 평가 : 지역별, 2019-2032년
  • 북미
    • 북미 : 구성요소별, 2019-2032년
    • 북미 : 용도별, 2019-2032년
    • 북미 : 최종사용자별, 2019-2032년
    • 미국
    • 캐나다
  • 유럽
    • 유럽 : 구성요소별, 2019-2032년
    • 유럽 : 용도별, 2019-2032년
    • 유럽 : 최종사용자별, 2019-2032년
    • 영국
    • 프랑스
    • 독일
    • 이탈리아
    • 스페인
    • 네덜란드
    • 러시아
    • 기타 유럽
  • 아시아태평양
    • 아시아태평양 : 구성요소별, 2019-2032년
    • 아시아태평양 : 용도별, 2019-2032년
    • 아시아태평양 : 최종사용자별, 2019-2032년
    • 중국
    • 인도
    • 말레이시아
    • 일본
    • 인도네시아
    • 한국
    • 호주
    • 기타 아시아태평양
  • 중동 및 아프리카
    • 중동 및 아프리카 : 구성요소별, 2019-2032년
    • 중동 및 아프리카 : 용도별, 2019-2032년
    • 중동 및 아프리카 : 최종사용자별, 2019-2032년
    • 사우디아라비아
    • 아랍에미리트
    • 이스라엘
    • 남아프리카공화국
    • 기타 중동 및 아프리카
  • 라틴아메리카
    • 라틴아메리카 : 구성요소별, 2019-2032년
    • 라틴아메리카 : 용도별, 2019-2032년
    • 라틴아메리카 : 최종사용자별, 2019-2032년
    • 멕시코
    • 브라질
    • 아르헨티나
    • 기타 라틴아메리카

제9장 경쟁 상황

  • 확대와 인수 분석
    • 확대
    • 인수
  • 제휴/협업/합의/공개

제10장 기업 개요

  • Emulate Inc.
  • TissUse GmbH
  • MIMETAS BV
  • InSphero AG
  • CN Bio Innovations Ltd.
  • Kirkstall Ltd.
  • Hurel Corporation
  • AIM Biotech
  • Elveflow
  • Blacktrace Holdings Ltd
  • Tara Biosystems Inc.
  • Ascendance Biotechnology Inc.
  • Synthecon Incorporated
  • Fluidigm Corporation
  • Organovo Holdings Inc.
ksm 24.10.10

The global 3D microfluidic cell culture market size is expected to reach USD 393.95 million by 2032, according to a new study by Polaris Market Research. The report "Global 3D Microfluidic Cell Culture Market Size, Share, Trends, Industry Analysis Report: By Component (3D Microfluidic Devices, Media, Reagents, and Consumables), By Application, By End-User, and By Region (North America, Europe, Asia Pacific, Latin America and Middle East & Africa) - Market Forecast, 2024 - 2032." gives a detailed insight into current market dynamics and provides analysis on future market growth.

The 3D microfluidic cell culture market is experiencing significant growth driven by advancements in cell biology, increased demand for high-fidelity in vitro models, and rising investments in research and development. Key drivers include the need for more accurate drug testing and disease modeling, as traditional 2D cultures often fail to mimic the complexity of human tissues. Opportunities are expanding with technological innovations such as integrated sensors and advanced materials, which enhance the functionality and scalability of microfluidic systems. Trends like the integration of artificial intelligence for data analysis and the development of personalized medicine further boost market potential. Overall, the market is anticipated to grow steadily as it continues to address the limitations of existing cell culture methods and supports advancements in biotechnology and pharmaceuticals.

Technological advancements in microfluidics enhance the precision and control of cellular environments, enabling more accurate simulation of physiological conditions driving the market revenue. The growing need for advanced in vitro models in drug discovery and personalized medicine further fuels demand, as these systems offer improved predictions of human responses and disease modeling. Additionally, increasing investment in biomedical research and the shift towards high-throughput screening methods contribute to market growth.

3D Microfluidic Cell Culture Market Report Highlights

The 3D microfluidic devices segment is the dominant force, driven by the increasing adoption of advanced cell culture systems and a growing focus on improving experimental accuracy. This segment is expected to see the highest growth due to continuous technological innovations enhancing device performance.

The drug discovery and development segment lead the market, as there is a rising demand for high-throughput and predictive models to streamline the drug development process. This application is anticipated to maintain robust growth due to its critical role in accelerating pharmaceutical research.

Key players in the 3D microfluidic cell culture market include Emulate Inc., TissUse GmbH, MIMETAS BV, InSphero AG, CN Bio Innovations Ltd., Kirkstall Ltd., Hurel Corporation, AIM Biotech, Elveflow, Blacktrace Holdings Ltd., Tara Biosystems Inc., Ascendance Biotechnology Inc., Synthecon Incorporated, Fluidigm Corporation, and Organovo Holdings Inc.

North America is the dominant region, benefiting from a strong presence of leading biotechnology firms and substantial research funding. Also, the Asia Pacific region is experiencing the highest growth rate, fueled by rapid advancements in research infrastructure and increasing investments in healthcare innovation.

Polaris Market Research has segmented the 3D microfluidic cell culture market report based on component, application, end user, and region

3D Microfluidic Cell Culture - Component Outlook (Revenue - USD bllion, 2019 - 2032)

  • 3D Microfluidic Devices
  • Media
  • Reagents
  • Consumables

3D Microfluidic Cell Culture - Application Outlook (Revenue - USD billion, 2019 - 2032)

  • Drug Discovery & Development
  • Tissue Engineering
  • Regenerative Medicine
  • Cancer Research
  • Stem Cell Research
  • Organ-on-a-Chip
  • Toxicology Testing
  • Disease Modeling
  • Others

3D Microfluidic Cell Culture - End User Outlook (Revenue - USD billion, 2019 - 2032)

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Hospitals & Diagnostic Centers
  • Contract Research Organizations (CROs)
  • Others

3D Microfluidic Cell Culture - Regional Outlook (Revenue - USD billion, 2019 - 2032)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global 3D Microfluidic Cell Culture Market Insights

  • 4.1. 3D Microfluidic Cell Culture Market - Market Snapshot
  • 4.2. 3D Microfluidic Cell Culture Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Integration of AI and Machine Learning is driving the market growth
      • 4.2.1.2. Development of High-Throughput Screening Platforms propels the market
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. The Initial Investment in 3D Microfluidic Cell Culture Technology is Hindering Market Growth
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. 3D Microfluidic Cell Culture Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global 3D Microfluidic Cell Culture Market, by Component

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global 3D Microfluidic Cell Culture Market, by Component, 2019-2032 (USD million)
  • 5.3. 3D Microfluidic Devices
    • 5.3.1. Global 3D Microfluidic Cell Culture Market, by 3D Microfluidic Devices, by Region, 2019-2032 (USD million)
  • 5.4. Media
    • 5.4.1. Global 3D Microfluidic Cell Culture Market, by Media, by Region, 2019-2032 (USD million)
  • 5.5. Reagents
    • 5.5.1. Global 3D Microfluidic Cell Culture Market, by Reagents, by Region, 2019-2032 (USD million)
  • 5.6. Consumables
    • 5.6.1. Global 3D Microfluidic Cell Culture Market, by Consumables, by Region, 2019-2032 (USD million)

6. Global 3D Microfluidic Cell Culture Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global 3D Microfluidic Cell Culture Market, by Application, 2019-2032 (USD million)
  • 6.3. Drug Discovery & Development
    • 6.3.1. Global 3D Microfluidic Cell Culture Market, by Drug Discovery & Development, by Region, 2019-2032 (USD million)
  • 6.4. Tissue Engineering
    • 6.4.1. Global 3D Microfluidic Cell Culture Market, by Tissue Engineering, by Region, 2019-2032 (USD million)
  • 6.5. Regenerative Medicine
    • 6.5.1. Global 3D Microfluidic Cell Culture Market, by Regenerative Medicine, by Region, 2019-2032 (USD million)
  • 6.6. Cancer Research
    • 6.6.1. Global 3D Microfluidic Cell Culture Market, by Cancer Research, by Region, 2019-2032 (USD million)
  • 6.7. Stem Cell Research
    • 6.7.1. Global 3D Microfluidic Cell Culture Market, by Stem Cell Research, by Region, 2019-2032 (USD million)
  • 6.8. Organ-on-Chip
    • 6.8.1. Global 3D Microfluidic Cell Culture Market, by Organ-on-Chip, by Region, 2019-2032 (USD million)
  • 6.9. Toxicology Testing
    • 6.9.1. Global 3D Microfluidic Cell Culture Market, by Toxicology Testing, by Region, 2019-2032 (USD million)
  • 6.10. Disease Modeling
    • 6.10.1. Global 3D Microfluidic Cell Culture Market, by Disease Modeling, by Region, 2019-2032 (USD million)
  • 6.11. Others
    • 6.11.1. Global 3D Microfluidic Cell Culture Market, by Others, by Region, 2019-2032 (USD million)

7. Global 3D Microfluidic Cell Culture Market, by End User

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global 3D Microfluidic Cell Culture Market, by End User, 2019-2032 (USD million)
  • 7.3. Pharmaceutical & Biotechnology Companies
    • 7.3.1. Global 3D Microfluidic Cell Culture Market, by Pharmaceutical & Biotechnology Companies, by Region, 2019-2032 (USD million)
  • 7.4. Academic & Research Institutes
    • 7.4.1. Global 3D Microfluidic Cell Culture Market, by Academic & Research Institutes, by Region, 2019-2032 (USD million)
  • 7.5. Hospitals & Diagnostic Centers
    • 7.5.1. Global 3D Microfluidic Cell Culture Market, by Hospitals & Diagnostic Centers, by Region, 2019-2032 (USD million)
  • 7.6. Contract Research Organizations (CROs)
    • 7.6.1. Global 3D Microfluidic Cell Culture Market, by Contract Research Organizations (CROs), by Region, 2019-2032 (USD million)
  • 7.7. Others
    • 7.7.1. Global 3D Microfluidic Cell Culture Market, by Hospitals & Diagnostic Centers, by Region, 2019-2032 (USD million)

8. Global 3D Microfluidic Cell Culture Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. 3D Microfluidic Cell Culture Market Assessment, By Geography, 2019-2032 (USD million)
  • 8.3. 3D Microfluidic Cell Culture Market - North America
    • 8.3.1. North America: 3D Microfluidic Cell Culture Market, by Component, 2019-2032 (USD million)
    • 8.3.2. North America: 3D Microfluidic Cell Culture Market, by Application, 2019-2032 (USD million)
    • 8.3.3. North America: 3D Microfluidic Cell Culture Market, by End User, 2019-2032 (USD million)
    • 8.3.4. 3D Microfluidic Cell Culture Market - U.S.
      • 8.3.4.1. U.S.: 3D Microfluidic Cell Culture Market, by Component, 2019-2032 (USD million)
      • 8.3.4.2. U.S.: 3D Microfluidic Cell Culture Market, by Application, 2019-2032 (USD million)
      • 8.3.4.3. U.S.: 3D Microfluidic Cell Culture Market, by End User, 2019-2032 (USD million)
    • 8.3.5. 3D Microfluidic Cell Culture Market - Canada
      • 8.3.5.1. Canada: 3D Microfluidic Cell Culture Market, by Component, 2019-2032 (USD million)
      • 8.3.5.2. Canada: 3D Microfluidic Cell Culture Market, by Application, 2019-2032 (USD million)
      • 8.3.5.3. Canada: 3D Microfluidic Cell Culture Market, by End User, 2019-2032 (USD million)
  • 8.4. 3D Microfluidic Cell Culture Market - Europe
    • 8.4.1. Europe: 3D Microfluidic Cell Culture Market, by Component, 2019-2032 (USD million)
    • 8.4.2. Europe: 3D Microfluidic Cell Culture Market, by Application, 2019-2032 (USD million)
    • 8.4.3. Europe: 3D Microfluidic Cell Culture Market, by End User, 2019-2032 (USD million)
    • 8.4.4. 3D Microfluidic Cell Culture Market - UK
      • 8.4.4.1. UK: 3D Microfluidic Cell Culture Market, by Component, 2019-2032 (USD million)
      • 8.4.4.2. UK: 3D Microfluidic Cell Culture Market, by Application, 2019-2032 (USD million)
      • 8.4.4.3. UK: 3D Microfluidic Cell Culture Market, by End User, 2019-2032 (USD million)
    • 8.4.5. 3D Microfluidic Cell Culture Market - France
      • 8.4.5.1. France: 3D Microfluidic Cell Culture Market, by Component, 2019-2032 (USD million)
      • 8.4.5.2. France: 3D Microfluidic Cell Culture Market, by Application, 2019-2032 (USD million)
      • 8.4.5.3. France: 3D Microfluidic Cell Culture Market, by End User, 2019-2032 (USD million)
    • 8.4.6. 3D Microfluidic Cell Culture Market - Germany
      • 8.4.6.1. Germany: 3D Microfluidic Cell Culture Market, by Component, 2019-2032 (USD million)
      • 8.4.6.2. Germany: 3D Microfluidic Cell Culture Market, by Application, 2019-2032 (USD million)
      • 8.4.6.3. Germany: 3D Microfluidic Cell Culture Market, by End User, 2019-2032 (USD million)
    • 8.4.7. 3D Microfluidic Cell Culture Market - Italy
      • 8.4.7.1. Italy: 3D Microfluidic Cell Culture Market, by Component, 2019-2032 (USD million)
      • 8.4.7.2. Italy: 3D Microfluidic Cell Culture Market, by Application, 2019-2032 (USD million)
      • 8.4.7.3. Italy: 3D Microfluidic Cell Culture Market, by End User, 2019-2032 (USD million)
    • 8.4.8. 3D Microfluidic Cell Culture Market - Spain
      • 8.4.8.1. Spain: 3D Microfluidic Cell Culture Market, by Component, 2019-2032 (USD million)
      • 8.4.8.2. Spain: 3D Microfluidic Cell Culture Market, by Application, 2019-2032 (USD million)
      • 8.4.8.3. Spain: 3D Microfluidic Cell Culture Market, by End User, 2019-2032 (USD million)
    • 8.4.9. 3D Microfluidic Cell Culture Market - Netherlands
      • 8.4.9.1. Netherlands: 3D Microfluidic Cell Culture Market, by Component, 2019-2032 (USD million)
      • 8.4.9.2. Netherlands: 3D Microfluidic Cell Culture Market, by Application, 2019-2032 (USD million)
      • 8.4.9.3. Netherlands: 3D Microfluidic Cell Culture Market, by End User, 2019-2032 (USD million)
    • 8.4.10. 3D Microfluidic Cell Culture Market - Russia
      • 8.4.10.1. Russia: 3D Microfluidic Cell Culture Market, by Component, 2019-2032 (USD million)
      • 8.4.10.2. Russia: 3D Microfluidic Cell Culture Market, by Application, 2019-2032 (USD million)
      • 8.4.10.3. Russia: 3D Microfluidic Cell Culture Market, by End User, 2019-2032 (USD million)
    • 8.4.11. 3D Microfluidic Cell Culture Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: 3D Microfluidic Cell Culture Market, by Component, 2019-2032 (USD million)
      • 8.4.11.2. Rest of Europe: 3D Microfluidic Cell Culture Market, by Application, 2019-2032 (USD million)
      • 8.4.11.3. Rest of Europe: 3D Microfluidic Cell Culture Market, by End User, 2019-2032 (USD million)
  • 8.5. 3D Microfluidic Cell Culture Market - Asia Pacific
    • 8.5.1. Asia Pacific: 3D Microfluidic Cell Culture Market, by Component, 2019-2032 (USD million)
    • 8.5.2. Asia Pacific: 3D Microfluidic Cell Culture Market, by Application, 2019-2032 (USD million)
    • 8.5.3. Asia Pacific: 3D Microfluidic Cell Culture Market, by End User, 2019-2032 (USD million)
    • 8.5.4. 3D Microfluidic Cell Culture Market - China
      • 8.5.4.1. China: 3D Microfluidic Cell Culture Market, by Component, 2019-2032 (USD million)
      • 8.5.4.2. China: 3D Microfluidic Cell Culture Market, by Application, 2019-2032 (USD million)
      • 8.5.4.3. China: 3D Microfluidic Cell Culture Market, by End User, 2019-2032 (USD million)
    • 8.5.5. 3D Microfluidic Cell Culture Market - India
      • 8.5.5.1. India: 3D Microfluidic Cell Culture Market, by Component, 2019-2032 (USD million)
      • 8.5.5.2. India: 3D Microfluidic Cell Culture Market, by Application, 2019-2032 (USD million)
      • 8.5.5.3. India: 3D Microfluidic Cell Culture Market, by End User, 2019-2032 (USD million)
    • 8.5.6. 3D Microfluidic Cell Culture Market - Malaysia
      • 8.5.6.1. Malaysia: 3D Microfluidic Cell Culture Market, by Component, 2019-2032 (USD million)
      • 8.5.6.2. Malaysia: 3D Microfluidic Cell Culture Market, by Application, 2019-2032 (USD million)
      • 8.5.6.3. Malaysia: 3D Microfluidic Cell Culture Market, by End User, 2019-2032 (USD million)
    • 8.5.7. 3D Microfluidic Cell Culture Market - Japan
      • 8.5.7.1. Japan: 3D Microfluidic Cell Culture Market, by Component, 2019-2032 (USD million)
      • 8.5.7.2. Japan: 3D Microfluidic Cell Culture Market, by Application, 2019-2032 (USD million)
      • 8.5.7.3. Japan: 3D Microfluidic Cell Culture Market, by End User, 2019-2032 (USD million)
    • 8.5.8. 3D Microfluidic Cell Culture Market - Indonesia
      • 8.5.8.1. Indonesia: 3D Microfluidic Cell Culture Market, by Component, 2019-2032 (USD million)
      • 8.5.8.2. Indonesia: 3D Microfluidic Cell Culture Market, by Application, 2019-2032 (USD million)
      • 8.5.8.3. Indonesia: 3D Microfluidic Cell Culture Market, by End User, 2019-2032 (USD million)
    • 8.5.9. 3D Microfluidic Cell Culture Market - South Korea
      • 8.5.9.1. South Korea: 3D Microfluidic Cell Culture Market, by Component, 2019-2032 (USD million)
      • 8.5.9.2. South Korea: 3D Microfluidic Cell Culture Market, by Application, 2019-2032 (USD million)
      • 8.5.9.3. South Korea: 3D Microfluidic Cell Culture Market, by End User, 2019-2032 (USD million)
    • 8.5.10. 3D Microfluidic Cell Culture Market - Australia
      • 8.5.10.1. Australia: 3D Microfluidic Cell Culture Market, by Component, 2019-2032 (USD million)
      • 8.5.10.2. Australia: 3D Microfluidic Cell Culture Market, by Application, 2019-2032 (USD million)
      • 8.5.10.3. Australia: 3D Microfluidic Cell Culture Market, by End User, 2019-2032 (USD million)
    • 8.5.11. 3D Microfluidic Cell Culture Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: 3D Microfluidic Cell Culture Market, by Component, 2019-2032 (USD million)
      • 8.5.11.2. Rest of Asia Pacific: 3D Microfluidic Cell Culture Market, by Application, 2019-2032 (USD million)
      • 8.5.11.3. Rest of Asia Pacific: 3D Microfluidic Cell Culture Market, by End User, 2019-2032 (USD million)
  • 8.6. 3D Microfluidic Cell Culture Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: 3D Microfluidic Cell Culture Market, by Component, 2019-2032 (USD million)
    • 8.6.2. Middle East & Africa: 3D Microfluidic Cell Culture Market, by Application, 2019-2032 (USD million)
    • 8.6.3. Middle East & Africa: 3D Microfluidic Cell Culture Market, by End User, 2019-2032 (USD million)
    • 8.6.4. 3D Microfluidic Cell Culture Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: 3D Microfluidic Cell Culture Market, by Component, 2019-2032 (USD million)
      • 8.6.4.2. Saudi Arabia: 3D Microfluidic Cell Culture Market, by Application, 2019-2032 (USD million)
      • 8.6.4.3. Saudi Arabia: 3D Microfluidic Cell Culture Market, by End User, 2019-2032 (USD million)
    • 8.6.5. 3D Microfluidic Cell Culture Market - UAE
      • 8.6.5.1. UAE: 3D Microfluidic Cell Culture Market, by Component, 2019-2032 (USD million)
      • 8.6.5.2. UAE: 3D Microfluidic Cell Culture Market, by Application, 2019-2032 (USD million)
      • 8.6.5.3. UAE: 3D Microfluidic Cell Culture Market, by End User, 2019-2032 (USD million)
    • 8.6.6. 3D Microfluidic Cell Culture Market - Israel
      • 8.6.6.1. Israel: 3D Microfluidic Cell Culture Market, by Component, 2019-2032 (USD million)
      • 8.6.6.2. Israel: 3D Microfluidic Cell Culture Market, by Application, 2019-2032 (USD million)
      • 8.6.6.3. Israel: 3D Microfluidic Cell Culture Market, by End User, 2019-2032 (USD million)
    • 8.6.7. 3D Microfluidic Cell Culture Market - South Africa
      • 8.6.7.1. South Africa: 3D Microfluidic Cell Culture Market, by Component, 2019-2032 (USD million)
      • 8.6.7.2. South Africa: 3D Microfluidic Cell Culture Market, by Application, 2019-2032 (USD million)
      • 8.6.7.3. South Africa: 3D Microfluidic Cell Culture Market, by End User, 2019-2032 (USD million)
    • 8.6.8. 3D Microfluidic Cell Culture Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: 3D Microfluidic Cell Culture Market, by Component, 2019-2032 (USD million)
      • 8.6.8.2. Rest of Middle East & Africa: 3D Microfluidic Cell Culture Market, by Application, 2019-2032 (USD million)
      • 8.6.8.3. Rest of Middle East & Africa: 3D Microfluidic Cell Culture Market, by End User, 2019-2032 (USD million)
  • 8.7. 3D Microfluidic Cell Culture Market - Latin America
    • 8.7.1. Latin America: 3D Microfluidic Cell Culture Market, by Component, 2019-2032 (USD million)
    • 8.7.2. Latin America: 3D Microfluidic Cell Culture Market, by Application, 2019-2032 (USD million)
    • 8.7.3. Latin America: 3D Microfluidic Cell Culture Market, by End User, 2019-2032 (USD million)
    • 8.7.4. 3D Microfluidic Cell Culture Market - Mexico
      • 8.7.4.1. Mexico: 3D Microfluidic Cell Culture Market, by Component, 2019-2032 (USD million)
      • 8.7.4.2. Mexico: 3D Microfluidic Cell Culture Market, by Application, 2019-2032 (USD million)
      • 8.7.4.3. Mexico: 3D Microfluidic Cell Culture Market, by End User, 2019-2032 (USD million)
    • 8.7.5. 3D Microfluidic Cell Culture Market - Brazil
      • 8.7.5.1. Brazil: 3D Microfluidic Cell Culture Market, by Component, 2019-2032 (USD million)
      • 8.7.5.2. Brazil: 3D Microfluidic Cell Culture Market, by Application, 2019-2032 (USD million)
      • 8.7.5.3. Brazil: 3D Microfluidic Cell Culture Market, by End User, 2019-2032 (USD million)
    • 8.7.6. 3D Microfluidic Cell Culture Market - Argentina
      • 8.7.6.1. Argentina: 3D Microfluidic Cell Culture Market, by Component, 2019-2032 (USD million)
      • 8.7.6.2. Argentina: 3D Microfluidic Cell Culture Market, by Application, 2019-2032 (USD million)
      • 8.7.6.3. Argentina: 3D Microfluidic Cell Culture Market, by End User, 2019-2032 (USD million)
    • 8.7.7. 3D Microfluidic Cell Culture Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: 3D Microfluidic Cell Culture Market, by Component, 2019-2032 (USD million)
      • 8.7.7.2. Rest of Latin America: 3D Microfluidic Cell Culture Market, by Application, 2019-2032 (USD million)
      • 8.7.7.3. Rest of Latin America: 3D Microfluidic Cell Culture Market, by End User, 2019-2032 (USD million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Emulate Inc.
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. TissUse GmbH
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. MIMETAS BV
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. InSphero AG
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. CN Bio Innovations Ltd.
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Kirkstall Ltd.
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Hurel Corporation
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. AIM Biotech
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Elveflow
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Blacktrace Holdings Ltd
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Tara Biosystems Inc.
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Ascendance Biotechnology Inc.
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Synthecon Incorporated
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Fluidigm Corporation
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
  • 10.15. Organovo Holdings Inc.
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Development
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제